<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T20:59:22+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2712】【2021 ASCO-GI】肝胆胰/神经内分泌肿瘤4项口头报告，重磅研究一文速览！</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/mirRumvQH752xqhgWLyhsg</id>
    <link href="https://mp.weixin.qq.com/s/mirRumvQH752xqhgWLyhsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【年度巨制】2020肿瘤资讯肺癌年终盘点即将重磅来袭！</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/cd5ud-Gx2H38EIKy5xeWKA</id>
    <link href="https://mp.weixin.qq.com/s/cd5ud-Gx2H38EIKy5xeWKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【Best of SABCS深圳】专家云集论道深圳，共话乳癌最新进展 —— 1月15日</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/qvaILcL2L3G3ihaaeIWZNA</id>
    <link href="https://mp.weixin.qq.com/s/qvaILcL2L3G3ihaaeIWZNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【专家采访】王洁教授：帕博利珠单抗（可瑞达）覆盖适应证广，疗效数据优异，慈善赠药计划切实为患者降低经济负担</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/pPAC8nhZfCwRyIxP9OehPw</id>
    <link href="https://mp.weixin.qq.com/s/pPAC8nhZfCwRyIxP9OehPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球近一半食管癌发生在中国，这与我们的传统饮食习惯有关</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/kch_10YvTvTOZZFcwWVeaQ</id>
    <link href="https://mp.weixin.qq.com/s/kch_10YvTvTOZZFcwWVeaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科研速递|丁克峰教授团队揭示外泌体ANGPTL1蛋白通过调控肝脏Kupffer细胞分泌谱抑制结直肠癌肝转移的机制</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/vikwZpHLg9jTdoAKpCsVZg</id>
    <link href="https://mp.weixin.qq.com/s/vikwZpHLg9jTdoAKpCsVZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>打过HPV四价疫苗，还需要打九价么？关于HPV疫苗的问题解答</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/rICoeZw7hdIc03Flnghskw</id>
    <link href="https://mp.weixin.qq.com/s/rICoeZw7hdIc03Flnghskw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免疫治疗真实世界研究患者数据报告</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/ztgKOnSfQgF5t9OHgyz6Kw</id>
    <link href="https://mp.weixin.qq.com/s/ztgKOnSfQgF5t9OHgyz6Kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2711】【ASCO-GI】胃癌靶向治疗新突破！Bemarituzumab 一线治疗FGFR2b阳性胃癌PFS和OS双重获益！</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/d6Fjka44vyH5zo5jrlMilA</id>
    <link href="https://mp.weixin.qq.com/s/d6Fjka44vyH5zo5jrlMilA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「2020金研奖」其他肿瘤及转化单元入围名单揭晓</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/cuiFyp4WLbR0Ave4YgMA1g</id>
    <link href="https://mp.weixin.qq.com/s/cuiFyp4WLbR0Ave4YgMA1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COMMF医学分论坛圆桌丨Medical Affairs眼中的医药营销趋势</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/JaByicdx8UDudP_1gA0PSA</id>
    <link href="https://mp.weixin.qq.com/s/JaByicdx8UDudP_1gA0PSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【专家采访】诊疗一体化时代，黄健、张旭教授畅谈前列腺癌领域最新热点</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/gm0xULu4ct2o5EyD9j29Gg</id>
    <link href="https://mp.weixin.qq.com/s/gm0xULu4ct2o5EyD9j29Gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年度巨制丨「骨与软组织肿瘤药物盘点」SESSION 5：软组织肉瘤的新型化疗药物</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/J1_4GfpYigv30Jb1SvytSg</id>
    <link href="https://mp.weixin.qq.com/s/J1_4GfpYigv30Jb1SvytSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>孔北华教授：民族制药，造福国人，安可达为妇科肿瘤患者的良药之选</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/79KgEEedvq--2SwUTkZ5wA</id>
    <link href="https://mp.weixin.qq.com/s/79KgEEedvq--2SwUTkZ5wA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>即将登陆！跨越生存高度，中国首个Castleman病治疗药物司妥昔单抗即将到来</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/XTVI7lvRfbu1bbq0LvPDqw</id>
    <link href="https://mp.weixin.qq.com/s/XTVI7lvRfbu1bbq0LvPDqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NSCLC中获得性MET扩增与EGFR-TKI治疗高度相关（下）</title>
    <updated>2021-01-18T19:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/MP2uZ6wECzdg93YaOOnUAQ</id>
    <link href="https://mp.weixin.qq.com/s/MP2uZ6wECzdg93YaOOnUAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2710】「2020金研奖」血液系统肿瘤单元入围名单揭晓</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/J8PU02wJ5ohxJHhqerFM-A</id>
    <link href="https://mp.weixin.qq.com/s/J8PU02wJ5ohxJHhqerFM-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WCLC20 前瞻丨来看看免疫治疗更多的长期生存数据</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/akrihgYPBK7JOShvV7Om4Q</id>
    <link href="https://mp.weixin.qq.com/s/akrihgYPBK7JOShvV7Om4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2021 ASCO-GI】信迪利单抗联合CapeOx方案胃癌新辅助数据惊艳，或可成为局晚期胃癌术前治疗新选择</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/_cQlwPyBEskKiZejK449JQ</id>
    <link href="https://mp.weixin.qq.com/s/_cQlwPyBEskKiZejK449JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MET异常是ALK阳性肺癌中不可忽视的耐药机制（下）</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/uw1iE_LBAP3BvsnsFVMjXA</id>
    <link href="https://mp.weixin.qq.com/s/uw1iE_LBAP3BvsnsFVMjXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>